SCHEMBL6996715

SCHEMBL6996715

Oc1c[c]ccc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.47
LMNA P02545 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
PTGS1 P23219 1/20 0.46
SLC6A2 P23975 1/20 0.46
PTGS2 P35354 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HIF1A Q16665 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
LIPE Q05469 1/20 0.45
MAPT P10636 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MAPK1 P28482 1/20 0.44
ALPG P10696 1/20 0.42
PTK2B Q14289 1/20 0.42
HTR1A P08908 2/20 0.42
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7003209 0.86 APP (0.47) APPLMNACYP2C19CYP1A2PTGS1
SCHEMBL183414 0.84 MAPT (0.48) LMNACYP2C19CYP1A2PTGS1SLC6A2
SCHEMBL1616224 0.81 MAPT (0.55) CYP2C19LIPEMAPTTDP1L3MBTL1
SCHEMBL7243289 0.80 HTR1A (0.47) LMNALIPEMAPTTDP1L3MBTL1
SCHEMBL1446254 0.79 HPGD (0.46) HDAC6LIPEMAPTTDP1L3MBTL1
SCHEMBL11513558 0.79 RAB9A (0.46) LIPEMAPTTDP1L3MBTL1MAPK1
SCHEMBL1099955 0.79 MAPT (0.44) SLC6A2SLC6A3LIPEMAPTTDP1
SCHEMBL5315646 0.79 APP (0.47) APPLIPEMAPTTDP1L3MBTL1
SCHEMBL339374 0.78 HTR1A (0.53) APPCYP1A2LIPEMAPTTDP1
SCHEMBL182637 0.78 HTR1A (0.53) APPLMNACYP1A2HDAC6LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113784713-A Leukotriene synthesis inhibitors 纳吉斯制药股份有限公司 2021-12-10 CN disclosed
CN-1117093-C Pyrazolo [1, 5-a ] pyrimidine derivatives, their use and compositions OTSUKA PHARMA CO LTD (JP) 2003-08-06 CN disclosed
EP-1081149-B1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2003-04-02 EP disclosed
US-6372749-B1 PHARMACOLOGICAL EFFECTS SUCH AS ANALGESIC ACTION, INHIBITORY EFFECT ON NITROGEN MONOXIDE SYNTHETASE AND THE LIKE AND ARE USEFUL AS ANALGESICS. OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2002-04-16 US disclosed
CN-1299362-A Pyrazolo [1,5-a] pyrimidine derivatives OTSUKA PHARMA CO LTD (JP) 2001-06-13 CN disclosed
EP-1081149-A1 PYRAZOLO 1,5-a]PYRIMIDINE DERIVATIVES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2001-03-07 EP disclosed
CN-1227555-A Cytokine production inhibitors triazepine compounds, and intermediates thereof JAPAN TOBACCO INC (JP) 1999-09-01 CN disclosed
EP-0934940-A1 CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF Japan Tobacco Inc. (JP) 1999-08-11 EP disclosed
US-5807850-A Therapeutic agent for osteoporosis and triazepine compound JAPAN TOBACCO, INC. (JP) 1998-09-15 US disclosed
CN-1171788-A Therapeutic agent for osteoporosis and triaza * compound JAPAN TOBACCO INC (JP) 1998-01-28 CN disclosed
CN-1159325-A Co-therapy for Parkinson's syndrome PFIZER (US) 1997-09-17 CN disclosed
EP-0792880-A1 OSTEOPOROSIS REMEDY AND TRIAZEPINE COMPOUND Japan Tobacco Inc. (JP) 1997-09-03 EP disclosed